Skip to main content
OpenTrials
Completed

NCT Number: NCT06883942

Pilot Study on the Evaluation of the Functionality, Safety and Reliability of New Tripping Devices for Lower Limbs.

The study aims to identify prognostic biomarkers of fall risk in patients with lower limb amputation

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

IRCCS Fondazione Don Carlo Gnocchi

Florence, Italy, 50143

About this study

The protocol will involve both trans-tibial and trans-femoral amputation subjects, for a total duration of up to 5 sessions.

Initially, the fall detection algorithm will be evaluated on trans-femoral and trans-tibial amputees performing the test while wearing their prosthesis.

In a second step, the experimentally obtained prognostic markers of fall risk will be studied (i.e., using one or both of the perturbation platforms described below).

The markers thus obtained are to be validated by comparison with markers already established in clinical practice or in the literature.

Experimental platforms The platforms are composed of a mechanism to simulate and investigate the aid that the prosthetic system can provide in the event of a source of tripping and/or slipping.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Trans-femoral or trans-tibial lower limb amputation;
  • Functional medical classification: Level K3-K4;
  • Subjects who have had a prosthesis for at least 1 year (experienced wearers);
  • Informed consent signed by the subject

Exclusion criteria

  • Significant medical comorbidities (severe neurological disease, cardiovascular disease diabetes/unstabilised hypertension, severe sensory deficits);
  • Cardiac device wearers (PMK or AICD);
  • Cognitive impairment (MMSE adjusted for age and schooling <24);
  • Inability or unwillingness to provide informed consent;
  • Severe depressive symptomatology - Beck Depression Inventory (BDI-II <19);
  • Severe anxiety symptoms - State-Trait Anxiety Inventory (STAI-Y <50).

Treatment and study plan

prosthetic group performs the entire protocol with their own prosthesis

Procedure

The 1st session is the enrolment and functional evaluation one. The following 2 we test the algorithm functionality verification; one session for both platforms. The last 2 sessions are necessary to acquire prognostic markers for falls; one session for both platforms.

The balance disturbance tests will take place on two platforms:

  • The sliding platform consists of a metal supporting structure and a wooden cover, which has a manual release mechanism that allows the activation of the tile responsible for simulating the events that occur during sliding.
  • The stumbling platform consists of a metal supporting structure and a wooden cover, which features an electronically activated plastic and foam tripping mechanism that simulates the sequence of events that occur during a stumble.

Experimental Group

Device

The fall detection algorithm will be evaluated first. In a second step, the experimentally obtained prognostic markers of fall risk will be studied. The markers thus obtained shall be validated by comparison with markers already established in clinical practice or in the literature.

Primary outcomes

  1. algorithm validation

    Time frame: baseline

    Verifying the measurement performance of the trip and slip detection algorithm on prosthesis wearers

Secondary outcomes

  1. data aquiring

    Time frame: baseline

    Acquire data on amputees to be used for the development of a new version of the detection algorithm and its testing.

Sponsors and collaborators

Lead sponsor

Fondazione Don Carlo Gnocchi ETS

Other

Collaborators

  • Biorobotic Institute Scuola Superiore sant'Anna Pisa

Registry information

Acronym: MOTU++ pedane

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Mar 19, 2025
Registry last updated
Mar 27, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.